- Home
- IMA vs ZTEK Comparison
IMA vs ZTEK Comparison
Compare IMA & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMA | ZTEK |
|---|---|---|
| Founded | 2019 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.4M | 78.2M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | IMA | ZTEK |
|---|---|---|
| Price | $6.85 | $0.59 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | 45.4K | ★ 67.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.70 | $0.55 |
| 52 Week High | $17.50 | $1.84 |
Technical Indicators
Market Signals| Indicator | IMA | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 49.83 | 40.08 |
| Support Level | $6.65 | $0.55 |
| Resistance Level | $7.17 | $0.75 |
| Average True Range (ATR) | 0.39 | 0.05 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 32.25 | 25.00 |
Price Performance
Historical ComparisonAbout IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.